The expression of MYL4 has shown to abnormally persist in ventricular tissue of individuals with CHD [34], and the ventricular analog MYL3 is replaced by re-expression of MYL4 in failing and hypertrophied hearts, resembling a fetal remodeling pattern associated with ventricular dysfunction [33, 35]. This evidence concerns the gene MYL3 and coronary artery disorder.